IRINOTECAN
GastricCHIMERAtrial
Phase 3 small_molecule active
Quick answer
IRINOTECAN for Gastric Carcinoma is a Phase 3 program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COLLEGIUM PHARMACEUTICAL, INC
- Indication
- Gastric Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active